Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 3
2010 3
2011 2
2012 2
2013 6
2014 4
2015 4
2016 5
2017 5
2018 4
2019 7
2020 4
2021 6
2022 14
2023 10
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Results by year

Filters applied: . Clear all
Page 1
Editorial: Emerging Swine Viruses.
Perfumo CJ, Pereda A, Jongkaewwattana A, Chen Z, Perez DR, Ma J. Perfumo CJ, et al. Among authors: jongkaewwattana a. Front Vet Sci. 2020 Mar 24;7:132. doi: 10.3389/fvets.2020.00132. eCollection 2020. Front Vet Sci. 2020. PMID: 32270000 Free PMC article. No abstract available.
Immunogenicity and protective efficacy of SARS-CoV-2 mRNA vaccine encoding secreted non-stabilized spike in female mice.
Prompetchara E, Ketloy C, Alameh MG, Tharakhet K, Kaewpang P, Yostrerat N, Pitakpolrat P, Buranapraditkun S, Manopwisedjaroen S, Thitithanyanont A, Jongkaewwattana A, Hunsawong T, Im-Erbsin R, Reed M, Wijagkanalan W, Patarakul K, Techawiwattanaboon T, Palaga T, Lam K, Heyes J, Weissman D, Ruxrungtham K. Prompetchara E, et al. Among authors: jongkaewwattana a. Nat Commun. 2023 Apr 21;14(1):2309. doi: 10.1038/s41467-023-37795-0. Nat Commun. 2023. PMID: 37085495 Free PMC article.
Safety and immunogenicity of a prefusion non-stabilized spike protein mRNA COVID-19 vaccine: a phase I trial.
Gatechompol S, Kittanamongkolchai W, Ketloy C, Prompetchara E, Thitithanyanont A, Jongkaewwattana A, Buranapraditkun S, Alameh MG, Ubolyam S, Sophonphan J, Apornpong T, Kerr S, Kamarulzaman A, Siwamogsatham S, Kroon E, Puthanakit T, Patarakul K, Palaga T, Wijagkanalan W, Carpenter A, Hong L, Weissman D, Ruxrungtham K; ChulaVAC-001 study team. Gatechompol S, et al. Among authors: jongkaewwattana a. Nat Microbiol. 2022 Dec;7(12):1987-1995. doi: 10.1038/s41564-022-01271-0. Epub 2022 Nov 14. Nat Microbiol. 2022. PMID: 36376393 Clinical Trial.
Preclinical evaluation of immunogenicity, efficacy and safety of a recombinant plant-based SARS-CoV-2 RBD vaccine formulated with 3M-052-Alum adjuvant.
Phoolcharoen W, Shanmugaraj B, Khorattanakulchai N, Sunyakumthorn P, Pichyangkul S, Taepavarapruk P, Praserthsee W, Malaivijitnond S, Manopwisedjaroen S, Thitithanyanont A, Srisutthisamphan K, Jongkaewwattana A, Tomai M, Fox CB, Taychakhoonavudh S. Phoolcharoen W, et al. Among authors: jongkaewwattana a. Vaccine. 2023 Apr 24;41(17):2781-2792. doi: 10.1016/j.vaccine.2023.03.027. Epub 2023 Mar 21. Vaccine. 2023. PMID: 36963999 Free PMC article.
Assessment of safety and intranasal neutralizing antibodies of HPMC-based human anti-SARS-CoV-2 IgG1 nasal spray in healthy volunteers.
Imsuwansri T, Jongthitinon T, Pojdoung N, Meesiripan N, Sakarin S, Boonkrai C, Wongtangprasert T, Phakham T, Audomsun T, Attakitbancha C, Saelao P, Muanwien P, Tian MT, Tongchusak S, Sangruji B, Wannigama DL, Sawangmake C, Rodprasert W, Le QD, Purbantoro SD, Vasuntrarak K, Nantavisai S, Sirilak S, Uppapong B, Sapsutthipas S, Trisiriwanich S, Somporn T, Usoo A, Mingngamsup N, Phumiamorn S, Aumklad P, Arunprasert K, Patrojanasophon P, Opanasopit P, Pesirikan N, Nitisaporn L, Pitchayakorn J, Narkthong T, Mahong B, Chaiyo K, Srisutthisamphan K, Viriyakitkosol R, Aeumjaturapat S, Jongkaewwattana A, Bunnag S, Pisitkun T. Imsuwansri T, et al. Among authors: jongkaewwattana a. Sci Rep. 2023 Sep 20;13(1):15648. doi: 10.1038/s41598-023-42539-7. Sci Rep. 2023. PMID: 37730833 Free PMC article. Clinical Trial.
Single Ad26.COV2.S booster dose following two doses of BBIBP-CorV vaccine against SARS-CoV-2 infection in adults: Day 28 results of a phase 1/2 open-label trial.
Muangnoicharoen S, Wiangcharoen R, Nanthapisal S, Kamolratakul S, Lawpoolsri S, Jongkaewwattana A, Thitithanyanont A, Luvira V, Chinwangso P, Thanthamnu N, Chantratita N, Lim JK, Anh Wartel T, Excler JL, Ryser MF, Leong C, Mak TK, Pitisuttithum P. Muangnoicharoen S, et al. Among authors: jongkaewwattana a. Vaccine. 2023 Jul 19;41(32):4648-4657. doi: 10.1016/j.vaccine.2023.06.043. Epub 2023 Jun 15. Vaccine. 2023. PMID: 37344265 Free PMC article. Clinical Trial.
Monkeypox virus productively infects human induced pluripotent stem cell-derived astrocytes and neural progenitor cells.
Chailangkarn T, Teeravechyan S, Attasombat K, Thaweerattanasinp T, Sunchatawirul K, Suwanwattana P, Pongpirul K, Jongkaewwattana A. Chailangkarn T, et al. Among authors: jongkaewwattana a. J Infect. 2022 Dec;85(6):702-769. doi: 10.1016/j.jinf.2022.10.016. Epub 2022 Oct 19. J Infect. 2022. PMID: 36272454 Free PMC article. No abstract available.
73 results